Longevitas Labs, the first Spanish laboratory specialized in aging prevention, partners with Made of Genes, member of CataloniaBio & HealthTech, to present the innovative Personalized Bio-Genetic Study. 

SocialDiabetes, member of CataloniaBio & HealthTech, announces the launch of "Listen.Doctor", an AI-powered tool that transforms medical consultations into actionable knowledge. 

Google.org has announced that it will invest 200,000 euros in an artificial intelligence (AI) project focused on improving cancer patients called GrowAI by HumanITcare, member of CataloniaBio & HealthTech. 

The BC Link platform, developed by the biotechnology company Better Care, member of CataloniaBio & HealthTech, will be the first technology to be evaluated using the parameters agreed upon by all participants in the ASSESS-DHT project, which aims to standardize and harmonize the evaluation of Digital Health Technologies across Europe. 

CataloniaBio & HealthTech is launching a new space for analysing current affairs to give a voice to our main asset: the organisations and companies that are part of the association. A new opinion forum to make us stop and reflect on the effects that changes in the environment may have on companies in the health sector. On 13 March 2024, lawmakers in the European Parliament approved by majority vote a new law to regulate AI systems, the first-ever legal framework on artificial intelligence. This is what Casper Wilstrup, CEO of Abzu, has to say on the matter.

Mowoot, member of CataloniaBio & HealthTech, launched a project in collaboration with Eurecat, also members, and the Jordi Gol i Gurina Primary Care Research Foundation to develop a device that becomes the first effective therapy for the treatment of IBS. 

Medichem, member of CataloniaBio & HealthTech, is pleased to announce the appointment of Pablo Álvarez as its new Chief Executive Officer (CEO). With an excellent track record in the pharmaceutical industry and a commitment to lead Medichem into a new phase of growth and success. 

The Josep Carreras Leukaemia Research Institute, member of CataloniaBio & HealthTech, opens a new lab with the incorporation of Dr. Vincenzo Calvanese, a consolidated researcher on stem cell biology. The new group will try to understand which molecular features and regulatory processes identify a blood stem cell, a fundamental knowledge to advance in many areas, like haematopoietic stem cell transplant, one of the few successful clinical applications of stem cells today. 

Ship2B Ventures, member of CataloniaBio & HealthTech, is driving 10 pioneering impact startups in the healthcare field through the BSocial Impact Fund, supported by Banc Sabadell, the European Investment Fund and Axis. 

Oncoheroes Biosciences, member of CataloniaBio & HealthTech, announce a significant milestone in its mission to combat pediatric brain cancer. In a recent paper published in SLAS Discovery journal titled "Development of a High-Throughput Screening Platform to Identify New Therapeutic Agents for Medulloblastoma Group 3" authored by Inés Fallon, Henar Hernando, Olga Almacellas-Rabaiget, Berta Marti-Fuster, Cesare Spadoni, Darell D Bigner, and Eva Méndez, their team reveals the development of an innovative screening platform aimed at identifying potential drug candidates for medulloblastoma, a type of brain cancer prevalent in children 

Croda Pharma, member of CataloniaBio & HealthTech, has been awarded winner of a prestigious award for its process development for innovative ingredients, including its production of sustainably sourced Squalene to replace shark-derived squalene for the vaccine industry. 

Reig Jofre, member of CataloniaBio & HealthTech, announces an investment of 5.8 million euros in the biotechnological company Leanbio, also a member. This investment aims at vertical integration in the development, characterization, and production of biotechnological-based active ingredients. 

Some of the member companies of CataloniaBio & HealthTech have been recognised by the 500 startups that are revolutionising the healthcare sector. 

Professionals from the Hospital Sant Joan de Déu Barcelona shared the clinical needs they have identified in their daily work in paediatric care with around sixty attendees from around thirty companies and start-ups from CataloniaBio & HealthTech and the sector. It was held on the afternoon of Tuesday 9 April at the Auditori Plaza de l'Hospital Sant Joan de Déu. 

The Catalan biotechnology company GoodGut, part of the HIPRA group and a member of CataloniaBio & HealthTech, has developed a solution to improve the detection of alterations in the intestinal microbiota. It has published the results of a clinical study demonstrating that the use of its test in colorectal cancer screening reduces false positives by 20%. This would contribute to a better optimization of the available resources in the healthcare system, as it would reduce the number of unnecessary colonoscopies and avoid the discomfort of undergoing this procedure if it is not strictly necessary.  

The Josep Carreras Institute (IJC), member of CataloniaBio & HealthTech, has received the provisional resolution of accreditation as a Severo Ochoa Center of Excellence by the Ministry of Science, Innovation and Universities. The IJC is one of the 10 institutions that have received accreditation in the 2023 call, placing it among the best research centers in the country based on excellence, scientific contributions, talent attraction capacity, and economic and social impact, among others. 

Ferrer, member of CataloniaBio & HealthTech, reaches an agreement with the North American firm Verge Genomics to acquire the drug VRG50635, a potentially inhibitory molecule of the enzyme PIKfyve that could improve survival in amyotrophic lateral sclerosis (ALS) patients. 

Croda International Plc (Croda), member of CataloniaBio & HealthTech, and The Access to Advanced Health Institute (AAHI) announce the signing of a partnership agreement around innovation and development of adjuvant formulations, under which Croda and AAHI will leverage their combined expertise to make novel vaccine adjuvant formulations globally accessible, thereby advancing next generation, robust and durable vaccines. 

More than forty CEOs and managers of CataloniaBio & HealthTech met on Tuesday 20 March at the first edition of the CEO Council of 2024. The meeting was held at the HUB Cambra Digital, at the Barcelona Chamber of Commerce and the special guest was Oriol Pinya, president of SpainCap, co-founder of Abac Capital and vice-president of Barcelona Global and FemCat. The welcome was given by Mariona Serra, CEO of GoodGut (a company of the HIPRA group) and President of CataloniaBio & HealthTech.

The initiative, which recognises the best business award of the previous year in the life and health sciences sector in Catalonia, has reached its ten anniversary.  The Bioèxit Award, like the CataloniaBio & HealthTech Gala, celebrates its ten anniversary this 2024. In all these years, 13 CataloniaBio & HealthTech member companies have received the award, in addition to an individual award for business trajectory.